Evidence map›Paper›PMID 41486619›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Learned Conformational Space and Pharmacophore Into Molecular Foundational Model.

Lin Wang, Yifan Wu, Hao Luo, Minglong Liang, Yihang Zhou, Cheng Chen, Chris Liu, Jun Zhang, Yang Zhang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lin WangCenter for AI and Computational Biology, Institute of Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.ORCID https://orcid.org/0000-0003-2482-7638
Yifan WuCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Hao LuoDeepMed Technology (Suzhou) Co., Ltd, Suzhou, China.
Minglong LiangDeepMed Technology (Suzhou) Co., Ltd, Suzhou, China.
Yihang ZhouDepartment of Computer Science, School of Computing, National University of Singapore, Singapore, Singapore.
Cheng ChenDeepMed Technology (Suzhou) Co., Ltd, Suzhou, China.
Chris LiuDeepMed Technology (Suzhou) Co., Ltd, Suzhou, China.
Jun ZhangDeepMed Technology (Suzhou) Co., Ltd, Suzhou, China.
Yang ZhangCenter for AI and Computational Biology, Institute of Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China.ORCID https://orcid.org/0000-0002-2739-1916

Funding

Agency for Science, Technology and Research A*STAR H25J6a0034Fundamental Research Funds for the Central Universities, Peking Union Medical College #3332025054Singapore Ministry of Education MOET1251RES2309Singapore Ministry of Education MOET2EP20125-0039
6 · The paper itself

Abstract

The emergence of large-scale chemical pre-trained models has significantly advanced our ability to capture complex relationships between molecular structures and their functions. Despite the growing interest in molecular foundational model that provide versatile representations and support molecular optimization for downstream tasks, few efforts have integrated explicit chemical knowledge-such as conformational and pharmacophore information-into pre-training. Given the highly dynamic nature of small molecules in solution, their conformational changes upon target binding, and the critical role of pharmacophore complementarity, it is essential to incorporate these factors into molecular foundational modeling. Here, we present a molecular foundational model that integrates conformational-space and pharmacophore-similarity projections during pre-training to regularize the representation space. The model adopts an Ouroboros-like architecture, where the molecular graphs are encoded into 1D representation vectors via a graph neural network and subsequently reconstructed back into SMILES sequences through an autoregressive Transformer module. This dual-module design establishes a flexible and extensible framework for both representation learning and molecular generation within a unified latent space. Extensive experiments demonstrate that our model effectively addresses a variety of practical chemical challenges, including similarity-based virtual screening, targeted poly-pharmacology design, chemical property prediction, and directed molecular optimization.

Indexed as

artificial intelligenceconformational spacedrug discoverymolecular foundational modelmolecular generation

Identifiers

PMID41486619
PMCPMC13042461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.